|
1
|
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer.
|
Cancer Discov
|
2013
|
2.87
|
|
2
|
Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
|
J Natl Cancer Inst
|
2011
|
2.47
|
|
3
|
The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation.
|
Proc Natl Acad Sci U S A
|
2010
|
1.45
|
|
4
|
Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases.
|
J Biol Chem
|
2008
|
1.38
|
|
5
|
Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
|
J Neurosci
|
2005
|
1.35
|
|
6
|
Genetic and expression analysis of MET, MACC1, and HGF in metastatic colorectal cancer: response to met inhibition in patient xenografts and pathologic correlations.
|
Clin Cancer Res
|
2011
|
1.32
|
|
7
|
CD74-NRG1 fusions in lung adenocarcinoma.
|
Cancer Discov
|
2014
|
1.19
|
|
8
|
MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.
|
Cancer Res
|
2014
|
1.02
|
|
9
|
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors.
|
Int J Cancer
|
2011
|
0.93
|
|
10
|
Tyrosine phosphorylation of tau by the SRC family kinases lck and fyn.
|
Mol Neurodegener
|
2011
|
0.80
|